Release Date: 16/03/09 16:29 Summary: Half Yearly Report and Accounts Price Sensitive: No Download Document 288.35KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%